308 related articles for article (PubMed ID: 18544962)
1. Cancer stem cells in breast: current opinion and future challenges.
Charafe-Jauffret E; Monville F; Ginestier C; Dontu G; Birnbaum D; Wicha MS
Pathobiology; 2008; 75(2):75-84. PubMed ID: 18544962
[TBL] [Abstract][Full Text] [Related]
2. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
Kakarala M; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
[TBL] [Abstract][Full Text] [Related]
3. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy].
Ma Y; Wang HX
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):881-5. PubMed ID: 21223793
[No Abstract] [Full Text] [Related]
4. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
5. [Tumor stem cells--a possible scenario].
Kopper L; Hajdú M
Magy Onkol; 2006; 50(2):101-6. PubMed ID: 16888672
[TBL] [Abstract][Full Text] [Related]
6. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cells-research opportunities utilizing mathematical modeling.
Ashkenazi R; Jackson TL; Dontu G; Wicha MS
Stem Cell Rev; 2007 Jun; 3(2):176-82. PubMed ID: 17873350
[TBL] [Abstract][Full Text] [Related]
8. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
9. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
[TBL] [Abstract][Full Text] [Related]
11. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.
Zhou W; Wang G; Guo S
Biochim Biophys Acta; 2013 Dec; 1836(2):304-20. PubMed ID: 24183943
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
14. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells: tools and models to rely on.
Charafe-Jauffret E; Ginestier C; Birnbaum D
BMC Cancer; 2009 Jun; 9():202. PubMed ID: 19555472
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling as a therapeutic target for breast cancer treatment?
Han J; Hendzel MJ; Allalunis-Turner J
Breast Cancer Res; 2011 May; 13(3):210. PubMed ID: 21672271
[TBL] [Abstract][Full Text] [Related]
18. Stem cells of the breast and cancer therapy.
Groner B; Vafaizadeh V; Brill B; Klemmt P
Womens Health (Lond); 2010 Mar; 6(2):205-19. PubMed ID: 20187727
[TBL] [Abstract][Full Text] [Related]
19. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
[TBL] [Abstract][Full Text] [Related]
20. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
